Henry Schein (HSIC) Valuation Check After Exclusive CitoCBC Distribution Agreement [Yahoo! Finance]
Henry Schein, Inc. (HSIC)
Last henry schein, inc. earnings: 2/20 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=74322&p=irol-irhome
Company Research
Source: Yahoo! Finance
Henry Schein (HSIC) stock is in focus after the company secured exclusive U.S. distribution rights for CytoChip's FDA-cleared CitoCBC system, the first cartridge-based CBC device with a CLIA Waiver for point-of-care testing. See our latest analysis for Henry Schein. Investors have reacted positively to the CitoCBC agreement and recent M&A commentary, with the share price up 23.98% over the past 90 days and a 1-year total shareholder return of 8.82%. This suggests improving momentum after a softer 3-year period. If this kind of healthcare diagnostics story interests you, it could be a good moment to broaden your watchlist with healthcare stocks beyond Henry Schein. With the shares now at $78.08 and trading slightly above the average analyst price target, yet screening with a high internal value score and a large modeled intrinsic discount, is there still an opportunity here, or is the market already pricing in future growth? Henry Schein's most followed narrative pegs fair v
Show less
Read more
Impact Snapshot
Event Time:
HSIC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSIC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSIC alerts
High impacting Henry Schein, Inc. news events
Weekly update
A roundup of the hottest topics
HSIC
News
- Henry Schein Enters Exclusive Distribution Agreement for CytoChip’s CLIA-Waived Hematology AnalyzerBusiness Wire
- JPM26: Henry Schein focuses on high-margin, high-growth business as new CEO announced [Yahoo! Finance]Yahoo! Finance
- Henry Schein Names Frederick M. Lowery as Chief Executive OfficerBusiness Wire
- 2024???2032????????????:??????(CAGR)7.1%????2032????4?1700??????????? [CNET News]CNET News
- One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan [Yahoo! Finance]Yahoo! Finance
HSIC
Earnings
- 11/4/25 - Beat
HSIC
Sec Filings
- 1/12/26 - Form 8-K
- 12/23/25 - Form 8-K
- 12/23/25 - Form 8-K
- HSIC's page on the SEC website